8-K: Richardson Electronics Reports Mixed Q3 Results Amidst Strategic Diversification

Richardson Electronics reported a decrease in year-over-year sales for the third quarter of fiscal year 2024, but saw sequential improvements and declared a quarterly cash dividend.

Summary

• Richardson Electronics announced its third quarter fiscal year 2024 results, showing a 25.6% decrease in net sales compared to the same quarter last year, totaling $52.4 million.
• The company experienced a significant sales decline in its PMT segment, down $15.7 million, primarily due to lower sales to semiconductor wafer fabrication equipment customers.
• GES sales saw a slight increase of $0.1 million year-over-year, while Canvys sales decreased by $3.1 million due to customer pushouts.
• Richardson Healthcare sales increased by $0.7 million, driven by higher demand for CT tubes and parts.
• Despite the year-over-year sales decrease, the company saw an 18.7% sequential increase in sales, indicating improving business conditions.
• Inventory decreased by $4.0 million sequentially, reflecting a focus on improving working capital.
• The company's backlog decreased slightly to $147.7 million from $150.7 million in the previous quarter, with a decline in PMT and Canvys, but an increase in GES.
• Gross margin was 29.5%, down from 31.8% in the prior year's quarter, but would have been 31.0% without manufacturing under absorption.
• Net income for the quarter was $0.8 million, or $0.05 per diluted share, compared to $6.3 million, or $0.44 per diluted share in the same quarter last year.
• The company declared a $0.06 per share quarterly cash dividend.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant year-over-year declines in sales and profitability, although there are some positive signs such as sequential sales growth and inventory reduction. The company is facing challenges in key segments, which tempers the overall outlook.

Positives

• The company experienced an 18.7% sequential increase in sales, indicating a positive trend in business conditions.
• Inventory levels decreased by $4.0 million sequentially, demonstrating improved working capital management.
• GES backlog increased by $1.1 million from the previous quarter, showing strength in that segment.
• Richardson Healthcare sales increased by $0.7 million year-over-year, driven by higher demand for CT tubes and parts.
• The company declared a quarterly cash dividend of $0.06 per share, returning value to shareholders.

Negatives

• Net sales decreased by 25.6% year-over-year, primarily due to lower sales in the PMT and Canvys segments.
• PMT sales decreased by $15.7 million year-over-year due to lower sales to semiconductor wafer fabrication equipment customers.
• Canvys sales decreased by $3.1 million due to short-term customer pushouts in North America.
• Gross margin decreased to 29.5% from 31.8% in the prior year's quarter.
• Net income decreased significantly to $0.8 million, or $0.05 per diluted share, compared to $6.3 million, or $0.44 per diluted share in the same quarter last year.
• Operating income decreased to $1.0 million from $7.6 million in the prior year's third quarter.

Risks

• The company is facing challenges due to the cyclical nature of sales to semiconductor wafer fab customers, which had an $11.5 million negative impact on sales this quarter.
• The PMT segment is experiencing significant sales declines due to lower demand from semiconductor wafer fabrication equipment customers.
• Short-term customer pushouts in North America are impacting Canvys sales.
• The company's gross margin was negatively impacted by manufacturing under absorption.
• The company's operating income and net income have decreased significantly compared to the prior year.

Future Outlook

The company anticipates sequential sales growth in the fiscal 2024 fourth quarter, as well as further improvements in profitability, based on recent customer discussions indicating expected demand growth in the semiconductor and GES markets.

Management Comments

• The sequential increase in sales and profitability is encouraging, reflecting the benefits of our diversification strategies as well as our teams focus on enhancing profitability and strengthening our balance sheet.
• Overall, our net sales continue to reflect the cyclical nature of sales to semiconductor wafer fab customers that had an $11.5 million negative impact on sales during the quarter.
• As we navigate this period, the success of our GES business demonstrates the importance of our diversification strategies as well as our focus on providing more engineered solutions to our growing global customer base.
• Throughout fiscal 2024 we have focused on decreasing inventory levels to better align with expected demand across our markets after a period of inventory growth, caused by supply chain constraints over the past several years.
• Over the near-term, recent customer discussions indicate expected demand growth in the semiconductor and GES markets.

Industry Context

The results reflect the cyclical nature of the semiconductor industry, with a significant impact on Richardson Electronics' PMT segment. The company's diversification strategy, particularly the growth in the GES segment, is aimed at mitigating these cyclical effects. The company is also positioning itself to benefit from government stimulus programs and global energy transition trends.

Comparison to Industry Standards

• Richardson Electronics' performance in the semiconductor sector is weaker than some of its peers, such as Analog Devices or Texas Instruments, who have shown more resilience in the current market conditions.
• The company's healthcare segment is performing well, which is in line with the general trend of growth in the medical device and equipment market, similar to companies like GE Healthcare or Siemens Healthineers.
• The decrease in inventory is a positive sign, aligning with industry best practices for working capital management, similar to what companies like Arrow Electronics or Avnet aim for.
• The company's gross margin of 29.5% is lower than the average gross margin of many electronics component manufacturers, which often range from 30% to 40%.

Stakeholder Impact

• Shareholders will receive a quarterly cash dividend of $0.06 per share.
• Employees may be impacted by the company's focus on cost management and efficiency.
• Customers may experience changes in product availability and delivery times due to supply chain adjustments.
• Suppliers may be affected by the company's efforts to optimize inventory levels.

Next Steps

• The company will host a conference call on April 11, 2024, to discuss the third quarter results.
• The company will continue to focus on decreasing inventory levels and improving working capital.
• The company will pursue long-term growth strategies related to government stimulus programs and global energy transition trends.
• The company anticipates sequential sales growth in the fiscal 2024 fourth quarter.

Key Dates

Keywords

semiconductor, healthcare, engineered solutions, power grid, microwave tubes, display solutions, green energy, financial results, cash dividend, inventory, backlog, gross margin, net sales